ARTICLE | Clinical News
Lenvatinib: Additional Phase III data
October 12, 2015 7:00 AM UTC
Eisai Co. Ltd. (Tokyo:4523), Tokyo, Japan Product: Lenvatinib ( Lenvima) ( E7080) Business: Cancer Molecular target: Vascular endothelial growth factor (VEGF) receptor; Vascular endothelial growth f...